Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2018)
13 slides from Coloplast A/s Class B's investor day presentation, 2018
Slide 1: Chronic Care update
Chronic Care update Coloplast Capital Markets Day 2018 Kristian Villumsen, Executive Vice President, Chronic Care
Slide 2: Chronic Care constitutes the lion's share of Coloplast sales and we are strengthening our global position
Chronic Care constitutes the lion’s share of Coloplast sales and we are strengthening our global position Chronic Care sales Chronic Care organic growth vs. market growth by region DKKm, FY 16/17 >75% FY 16/17 of Coloplast sales 11.8 billion of DKK annual sales Chronic Care #1 global Europe Other De
Slide 3: We consistently outgrow the market guided by our three strategic themes
We consistently outgrow the market guided by our three strategic themes Our strategic themes Ostomy Care organic growth vs. market growth 15/16 – 17/18 9M YTD 1 15/16 16/17 9M 17/18 Continence Care organic growth vs. market growth 15/16 – 17/18 9M YTD 2 3 15/16 16/17 9M 17/18 Source: Coloplast Marke
Slide 4: With the launch of SenSura Mio Concave we now have a complete product portfolio across user needs
1 SUPERIOR AND CLINICALLY DIFFERENTIATED PRODUCTS With the launch of SenSura Mio® Concave we now have a complete product portfolio across user needs 53% Regular profile 13% Inward profile 34% Outward profile SenSura® Mio Flat SenSura® Mio Convex SenSura® Mio Concave New elastic adhesive for Clinical
Slide 5: We are continuously expanding our Accessories portfolio, strengthening users' customization opportunities
1 SUPERIOR AND CLINICALLY DIFFERENTIATED PRODUCTS We are continuously expanding our Accessories portfolio, strengthening users’ customization opportunities Our Accessories momentum is outpacing the market … … which translates into market share gains Accessories growth Market Share Revenue growth MAT
Slide 6: Our broad SpeediCath family caters to different user needs and addresses distinctive market trends
1 SUPERIOR AND CLINICALLY DIFFERENTIATED PRODUCTS Our broad SpeediCath® family caters to different user needs and addresses distinctive market trends SpeediCath® Family SpeediCath® Flex SpeediCath® Flex launched in 16 countries Compact and Flex products SpeediCath® Flex Coudé Pro speci- Revenue DKKm
Slide 7: Our Professional platform builds a strong connection with HCPs, providing valuable insights to Coloplast Care
2 UNIQUE CONSUMER RELATIONSHIP Our Professional platform builds a strong connection with HCPs, providing valuable insights to Coloplast Care Coloplast Professional is an education and …and input from local clinicians While our training yields best collaboration platform… advance Coloplast Care in cl
Slide 8: Our global Coloplast Care and DtC presence enable us to support users across countries and business areas
2 UNIQUE CONSUMER RELATIONSHIP Our global Coloplast Care and DtC presence enable us to support users across countries and business areas Over 1M consumers in our database Over 1M conversations with users across the globe Over 30 countries with a consumer setup New Bowel Care program implemented in 2
Slide 9: We have strengthened our position as a consumer healthcare company and now have direct distribution in our top 5 markets
2 UNIQUE CONSUMER RELATIONSHIP We have strengthened our position as a consumer healthcare company and now have direct distribution in our top 5 markets UK USA France Our direct Offering Present latest product innovation Provide friction-free product access Germany China Improve user experience (E-co
Slide 10: We are poised to sustain our growth agenda by investing in the strategic foundation of our business
3 NEXT LEVEL COMMERCIAL EXECUTION We are poised to sustain our growth agenda by investing in the strategic foundation of our business… Innovation Health Care Professionals Direct consumer model SenSura Mio® range is now a complete product portfolio across user needs Collaborate with HCPs to Expand o
Slide 11: As well as strengthening our position through investments into regional growth opportunities
3 NEXT LEVEL COMMERCIAL EXECUTION … as well as strengthening our position through investments into regional growth opportunities Region Europe US Emerging Markets DRIVE ACCESS TO RAISE THE BAR THE INDUSTRY’S FOR SERVICE IN BEST PRODUCTS THE INDUSTRY CONSUMERS FIRST DEVELOP A CULTURE OF COMMERCIAL EX
Slide 12: Our ambition remains to outgrow the market, which we will achieve through our strategic themes
Our ambition remains to outgrow the market, which we will achieve through our strategic themes Our strategic themes Our revenue ambition is to outgrow the market 1 5% - 6% 4% - 5% 2 3 Market growth - Annual organic • . Page 12
Slide 13: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /